Table 5.
Proportion of patients with events in the Post-implementation cohort based on HEART Pathway risk assessment
| Outcomes | Low-Risk N=1461 (%) |
Non-Low-Risk N=2531 (%) |
Incomplete N=769 (%) |
Percent Difference Low:Non-Low (95% CI)* |
Percent Difference Low:Incomplete (95% CI)* |
|---|---|---|---|---|---|
| Safety | |||||
| Index visit | |||||
| Death | 2 (0.1) | 12 (0.5) | 1 (0.1) | 0.3 (0.0–0.7) | 0.0 (−0.3–0.3) |
| MI | 1 (0.1) | 313 (12.4) | 0 (0) | 12.3 (11.0–13.6) | −0.1 (−0.2–0.1) |
| Revascularization | 1 (0.1) | 151 (6) | 2 (0.3) | 5.9 (5.0–6.8) | 0.2 (−0.2–0.6) |
| Death + MI | 3 (0.2) | 321 (12.7) | 1 (0.1) | 12.5 (11.2–13.8) | −0.1 (−0.4–0.3) |
| Death + MI + Revascularization | 4 (0.3) | 348 (13.7) | 3 (0.4) | 13.5 (12.1–14.8) | 0.1 (−0.4–0.6) |
| Follow-up period | |||||
| Death | 2 (0.1) | 19 (0.8) | 3 (0.4) | 0.6 (0.2–1.0) | 0.3 (−0.2–0.7) |
| MI | 1 (0.1) | 26 (1) | 2 (0.3) | 1.0 (0.5–1.4) | 0.2 (−0.2–0.6) |
| Revascularization | 1 (0.1) | 34 (1.3) | 3 (0.4) | 1.3 (0.8–1.7) | 0.3 (−0.1–0.8) |
| Death + MI | 3 (0.2) | 43 (1.7) | 5 (0.7) | 1.5 (0.9–2.0) | 0.4 (−0.2–1.1) |
| Death + MI + Revascularization | 4 (0.3) | 66 (2.6) | 7 (0.9) | 2.3 (1.7–3.0) | 0.6 (−0.1–1.4) |
| 30 day (Index + follow up) | |||||
| Death | 4 (0.3) | 31 (1.2) | 4 (0.5) | 1.0 (0.4–1.5) | 0.2 (−0.3–0.8) |
| MI | 2 (0.1) | 320 (12.6) | 2 (0.3) | 12.5 (11.2–13.8) | 0.1 (−0.3–0.5) |
| Revascularization | 2 (0.1) | 183 (7.2) | 5 (0.7) | 7.1 (6.1–8.1) | 0.5 (−0.1–1.1) |
| Death + MI | 6 (0.4) | 341 (13.5) | 6 (0.8) | 13.1 (11.7–14.4) | 0.4 (−0.3–1.1) |
| Death + MI + Revascularization | 7 (0.5) | 378 (14.9) | 10 (1.3) | 14.5 (13.0–15.9) | 0.8 (−0.1–1.7) |
|
Utilization |
|||||
| Index visit | |||||
| Hospitalization | 241 (16.5) | 2095 (82.8) | 246 (32) | 66.3 (63.9–68.7) | 15.5 (11.7–19.3) |
| Early discharge | 1203 (82.3) | 360 (14.2) | 483 (62.8) | −68.1 (−70.5−−65.7) | −19.5 (−23.5−−15.6) |
| Objective Cardiac Testing | 116 (7.9) | 1148 (45.4) | 43 (5.6) | 37.4 (35.0–39.8) | −2.3 (−4.5−−0.2) |
| Follow-up period | |||||
| Hospitalization | 43 (2.9) | 199 (7.9) | 29 (3.8) | 4.9 (3.6–6.3) | 0.8 (−0.8–2.4) |
| Objective Cardiac Testing | 43 (2.9) | 145 (5.7) | 18 (2.3) | 2.8 (1.5–4.0) | −0.6 (−2.0–0.8) |
| 30 day (Index + follow up) | |||||
| Hospitalization | 268 (18.3) | 2128 (84.1) | 253 (32.9) | 65.7 (63.3–68.2) | 14.6 (10.7–8.4) |
| Objective Cardiac Testing | 156 (10.7) | 1248 (49.3) | 58 (7.5) | 38.6 (36.1–41.1) | −3.1 (−5.6−−0.7) |
*
Proportions and associated 95%CI were calculated without adjustment for potential confounders.